NasdaqGS · Stocky rates: Avoid

Arxis, Inc. (ARXS)

$57.59 ▼ -3.37% as of 6 Aug, 20:26

Stocky turns companies like Arxis, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
27
/ 100
Avoid

What Stocky thinks

Avoid. Arxs scores 39.6/100 on Growth Compounder—weak revenue expansion relative to valuation—while Leadership Alignment (45/100) signals misaligned incentives and modest founder skin-in-the-game. At 69× forward P/E, the stock prices in perfection; analyst alpha of just 0.3% and sparse top-quartile conviction in 90 days reflect skepticism on delivery odds.

Compounder Score
40/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
45/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
0/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Analyst Sentiment
53/100
Top analysts' conviction — buy/hold/sell distribution + track record.

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Arxis, Inc.:

27
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 27/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

45
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

0
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Arxis, Inc. (ARXS) — frequently asked

Is Arxis, Inc. (ARXS) a good investment right now?

Stocky rates Arxis, Inc. (ARXS) at 27/100 — an Avoid — fundamentals or risks are too weak. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Avoid. Arxs scores 39.6/100 on Growth Compounder—weak revenue expansion relative to valuation—while Leadership Alignment (45/100) signals misaligned incentives and modest founder skin-in-the-game. At 69× forward P/E, the stock prices in per

What is ARXS's Stocky Verdict?

ARXS's current Stocky Verdict is 27/100, placing it in the "Avoid" band. This composite combines a 40/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.

Does Arxis, Inc. have a competitive moat?

Stocky hasn't finalised a Moat Score for Arxis, Inc. yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Arxis, Inc.'s leadership aligned with shareholders?

Arxis, Inc. scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to ARXS?

Arxis, Inc.'s Vulnerability Profile scores 0/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Arxis, Inc..

This is just the surface. See the whole picture on Arxis, Inc..

Sign up free and unlock the full analysis on ARXS — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering ARXS — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for ARXS.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how ARXS changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to ARXS?" · "Is ARXS overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
27
/ 100 · Avoid

See Arxis, Inc. the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in ARXS would be worth today.
Practice portfolio
Buy ARXS with virtual money and track it — zero risk.
Free · no real money · learn by doing Open ARXS in Stocky →

Or jump straight to the interactive dashboard for ARXS in the app.